page_banner

Products

Glycylglycine Cas: 556-50-3 99% Pulvis albus

Description:

Catalogue Number: XD90282
Cas: 556-50-3
Formulae hypotheticae: C4H8N2O3
Pondus hypotheticum: 132.11792
Availability: In Stock
Pretium:  
Prepack: 100g USD20
Mole Pack: Request Quote

 

 

 

 

 

 


Product Detail

Product Tags

Catalogue Number XD90282
Product Name Glycylglycine

CAS

556-50-3

Formulae hypotheticae

C4H8N2O3

M. Pondus

132.11792
Repono Details Ambiens

Tariff Code harmonized

29241900

 

Product Specification

Damnum in Siccatio <0.2%
Sulfate <0.02%
Assay 99%
Alia amino acida Non detectable
Transmittance >95%
Chloride <0.02%
Aspectus Album ut off-pulveris alba
Ferrum (Fe) <30ppm
Metallum grave (Pb) <10ppm
Aconitum (NH4) <0.02%
Arsenicum (ut As2O3) <1ppm
Residere ignitio (sicut sulphate)

<0.15%

 

Carbamoyl phosphas synthetasis 1 (CPS1) defectus ob mutationum CPS1 est rara autosomal-recessiva ureae cycli inordinatio faciens hyperammonemia quae ad mortem ducere potest vel gravem neurologicam detrimentum.CPS1 formationem phosphatam carbamoyl catalyzis ab ammonia, bicarbonate et duobus moleculis ATP, et activum allostericum N-acetyl-L-glutamatum requirit.Fuscae mutationes in tota regione coding CPS1 occurrunt, sed maxime in singulis familiis, cum parvo recursu.Insignes hic solum notae mutationis recurrentis CPS1, p.Val1013del, in undecim aegris descensus Turcorum finitimus invenitur utens genus suum silvestrem recombinantem vel mutant CPS1 in systemate baculoviro/insectorum cellularum expressum.Reactio global CPS1 et ATPase et ATP synthesis reactiones partiales qui reflectunt, respective, gradus bicarbonatus et carbamati phosphorylationi tentabantur.Invenimus genus ferox CPS1 et V1013del mutant significans aequalem expressionem comparabilem et puritatem, sed mutant CPS1 nullas significantes residuas actiones ostenderunt.In exemplari structurali CPS1, V1013 pertinet ad valde hydrophobicum aba-stratum in medio centrali β-schedae subdomain dominii phosphorylationi carbamati et proxima est cuniculi carbamati praedictae quae utrumque sites phosphorylationi coniungit.Studia haplotype suggessit quod p.Val1013del mutationem fundatoris est.Postremo, mutatio p.V1013 inactivates CPS1, sed enzymum crasse instabile vel insolubile non reddit.Recursum hanc peculiarem mutationem aegrorum Turcorum verisimile est ob effectorem conditoris, qui consentaneum est cum frequenti consanguinitate in hominum affecta observatis.


  • Previous:
  • Deinde:

  • Close

    Glycylglycine Cas: 556-50-3 99% Pulvis albus